Meza Soto EA, Gomez-Lujan M, Velasco Espinal JE, Apolo Fajardo IA, Mariscal H, Estrada García MN, et al. The Role of GLP-1 Receptor Agonists (Ozempic and Mounjaro) as Secondary Therapy in Chronic Kidney Disease. Rev. Cienc. Multidiscip. SAGA [Internet]. 2025 Sep. 20 [cited 2026 Apr. 11];2(3):973-91. Available from: https://revistasaga.org/index.php/saga/article/view/257